nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—Ototoxicity—Cisplatin—esophageal cancer	0.0637	0.0637	CcSEcCtD
Vancomycin—Extravasation—Carboplatin—esophageal cancer	0.05	0.05	CcSEcCtD
Vancomycin—Nephrotoxicity—Cisplatin—esophageal cancer	0.0402	0.0402	CcSEcCtD
Vancomycin—Phlebitis—Carboplatin—esophageal cancer	0.0367	0.0367	CcSEcCtD
Vancomycin—Rash macular—Capecitabine—esophageal cancer	0.023	0.023	CcSEcCtD
Vancomycin—Nephropathy toxic—Cisplatin—esophageal cancer	0.0223	0.0223	CcSEcCtD
Vancomycin—Serum creatinine increased—Cisplatin—esophageal cancer	0.0208	0.0208	CcSEcCtD
Vancomycin—Necrosis—Cisplatin—esophageal cancer	0.0163	0.0163	CcSEcCtD
Vancomycin—Infection—Carboplatin—esophageal cancer	0.0154	0.0154	CcSEcCtD
Vancomycin—Serum creatinine increased—Capecitabine—esophageal cancer	0.0153	0.0153	CcSEcCtD
Vancomycin—Tenderness—Cisplatin—esophageal cancer	0.0147	0.0147	CcSEcCtD
Vancomycin—Extravasation—Cisplatin—esophageal cancer	0.0147	0.0147	CcSEcCtD
Vancomycin—Hearing impaired—Cisplatin—esophageal cancer	0.0134	0.0134	CcSEcCtD
Vancomycin—Pain—Carboplatin—esophageal cancer	0.0133	0.0133	CcSEcCtD
Vancomycin—Azotaemia—Methotrexate—esophageal cancer	0.0132	0.0132	CcSEcCtD
Vancomycin—Wheezing—Cisplatin—esophageal cancer	0.0124	0.0124	CcSEcCtD
Vancomycin—Body temperature increased—Carboplatin—esophageal cancer	0.0123	0.0123	CcSEcCtD
Vancomycin—Fungal infection—Capecitabine—esophageal cancer	0.0122	0.0122	CcSEcCtD
Vancomycin—Rigors—Capecitabine—esophageal cancer	0.0115	0.0115	CcSEcCtD
Vancomycin—Phlebitis—Cisplatin—esophageal cancer	0.0108	0.0108	CcSEcCtD
Vancomycin—Deafness—Cisplatin—esophageal cancer	0.0104	0.0104	CcSEcCtD
Vancomycin—Hearing impaired—Capecitabine—esophageal cancer	0.0099	0.0099	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00959	0.00959	CcSEcCtD
Vancomycin—Fungal infection—Methotrexate—esophageal cancer	0.00908	0.00908	CcSEcCtD
Vancomycin—Necrosis—Methotrexate—esophageal cancer	0.00894	0.00894	CcSEcCtD
Vancomycin—Blood creatinine increased—Cisplatin—esophageal cancer	0.00869	0.00869	CcSEcCtD
Vancomycin—Hypokalaemia—Cisplatin—esophageal cancer	0.00845	0.00845	CcSEcCtD
Vancomycin—Extravasation—Methotrexate—esophageal cancer	0.00804	0.00804	CcSEcCtD
Vancomycin—Phlebitis—Capecitabine—esophageal cancer	0.00794	0.00794	CcSEcCtD
Vancomycin—Thrombophlebitis—Capecitabine—esophageal cancer	0.0079	0.0079	CcSEcCtD
Vancomycin—Deafness—Capecitabine—esophageal cancer	0.00765	0.00765	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00725	0.00725	CcSEcCtD
Vancomycin—Renal impairment—Capecitabine—esophageal cancer	0.00719	0.00719	CcSEcCtD
Vancomycin—Vasculitis—Methotrexate—esophageal cancer	0.00719	0.00719	CcSEcCtD
Vancomycin—Dermatitis bullous—Capecitabine—esophageal cancer	0.00716	0.00716	CcSEcCtD
Vancomycin—Renal failure—Cisplatin—esophageal cancer	0.00703	0.00703	CcSEcCtD
Vancomycin—Bradycardia—Cisplatin—esophageal cancer	0.00654	0.00654	CcSEcCtD
Vancomycin—Blood creatinine increased—Capecitabine—esophageal cancer	0.00641	0.00641	CcSEcCtD
Vancomycin—Connective tissue disorder—Cisplatin—esophageal cancer	0.00631	0.00631	CcSEcCtD
Vancomycin—Hypokalaemia—Capecitabine—esophageal cancer	0.00623	0.00623	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00616	0.00616	CcSEcCtD
Vancomycin—Tinnitus—Cisplatin—esophageal cancer	0.00599	0.00599	CcSEcCtD
Vancomycin—Flushing—Cisplatin—esophageal cancer	0.00596	0.00596	CcSEcCtD
Vancomycin—Thrombophlebitis—Methotrexate—esophageal cancer	0.00588	0.00588	CcSEcCtD
Vancomycin—Erythema—Cisplatin—esophageal cancer	0.00559	0.00559	CcSEcCtD
Vancomycin—Malnutrition—Cisplatin—esophageal cancer	0.00559	0.00559	CcSEcCtD
Vancomycin—Neutropenia—Capecitabine—esophageal cancer	0.00553	0.00553	CcSEcCtD
Vancomycin—Flatulence—Cisplatin—esophageal cancer	0.00551	0.00551	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.0054	0.0054	CcSEcCtD
Vancomycin—Muscle spasms—Cisplatin—esophageal cancer	0.00537	0.00537	CcSEcCtD
Vancomycin—Infestation NOS—Capecitabine—esophageal cancer	0.00527	0.00527	CcSEcCtD
Vancomycin—Infestation—Capecitabine—esophageal cancer	0.00527	0.00527	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00526	0.00526	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00523	0.00523	CcSEcCtD
Vancomycin—Renal failure—Capecitabine—esophageal cancer	0.00518	0.00518	CcSEcCtD
Vancomycin—Anaemia—Cisplatin—esophageal cancer	0.00517	0.00517	CcSEcCtD
Vancomycin—Urinary tract infection—Capecitabine—esophageal cancer	0.00512	0.00512	CcSEcCtD
Vancomycin—Agranulocytosis—Capecitabine—esophageal cancer	0.00492	0.00492	CcSEcCtD
Vancomycin—Bradycardia—Capecitabine—esophageal cancer	0.00482	0.00482	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00472	0.00472	CcSEcCtD
Vancomycin—Oedema peripheral—Capecitabine—esophageal cancer	0.00466	0.00466	CcSEcCtD
Vancomycin—Connective tissue disorder—Capecitabine—esophageal cancer	0.00465	0.00465	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00459	0.00459	CcSEcCtD
Vancomycin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00456	0.00456	CcSEcCtD
Vancomycin—Infection—Cisplatin—esophageal cancer	0.00453	0.00453	CcSEcCtD
Vancomycin—Erythema multiforme—Capecitabine—esophageal cancer	0.00447	0.00447	CcSEcCtD
Vancomycin—Nervous system disorder—Cisplatin—esophageal cancer	0.00447	0.00447	CcSEcCtD
Vancomycin—Thrombocytopenia—Cisplatin—esophageal cancer	0.00447	0.00447	CcSEcCtD
Vancomycin—Tachycardia—Cisplatin—esophageal cancer	0.00445	0.00445	CcSEcCtD
Vancomycin—Skin disorder—Cisplatin—esophageal cancer	0.00443	0.00443	CcSEcCtD
Vancomycin—Tinnitus—Capecitabine—esophageal cancer	0.00441	0.00441	CcSEcCtD
Vancomycin—Flushing—Capecitabine—esophageal cancer	0.00439	0.00439	CcSEcCtD
Vancomycin—Eosinophilia—Methotrexate—esophageal cancer	0.00436	0.00436	CcSEcCtD
Vancomycin—Hypotension—Cisplatin—esophageal cancer	0.00426	0.00426	CcSEcCtD
Vancomycin—Chills—Capecitabine—esophageal cancer	0.00425	0.00425	CcSEcCtD
Vancomycin—Erythema—Capecitabine—esophageal cancer	0.00412	0.00412	CcSEcCtD
Vancomycin—Malnutrition—Capecitabine—esophageal cancer	0.00412	0.00412	CcSEcCtD
Vancomycin—Neutropenia—Methotrexate—esophageal cancer	0.00412	0.00412	CcSEcCtD
Vancomycin—Dyspnoea—Cisplatin—esophageal cancer	0.00407	0.00407	CcSEcCtD
Vancomycin—Flatulence—Capecitabine—esophageal cancer	0.00406	0.00406	CcSEcCtD
Vancomycin—Back pain—Capecitabine—esophageal cancer	0.00398	0.00398	CcSEcCtD
Vancomycin—Muscle spasms—Capecitabine—esophageal cancer	0.00396	0.00396	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00394	0.00394	CcSEcCtD
Vancomycin—Infestation NOS—Methotrexate—esophageal cancer	0.00392	0.00392	CcSEcCtD
Vancomycin—Infestation—Methotrexate—esophageal cancer	0.00392	0.00392	CcSEcCtD
Vancomycin—Pain—Cisplatin—esophageal cancer	0.0039	0.0039	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00389	0.00389	CcSEcCtD
Vancomycin—Renal failure—Methotrexate—esophageal cancer	0.00386	0.00386	CcSEcCtD
Vancomycin—Anaemia—Capecitabine—esophageal cancer	0.00381	0.00381	CcSEcCtD
Vancomycin—Vertigo—Capecitabine—esophageal cancer	0.0037	0.0037	CcSEcCtD
Vancomycin—Agranulocytosis—Methotrexate—esophageal cancer	0.00366	0.00366	CcSEcCtD
Vancomycin—Palpitations—Capecitabine—esophageal cancer	0.00364	0.00364	CcSEcCtD
Vancomycin—Body temperature increased—Cisplatin—esophageal cancer	0.00361	0.00361	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00348	0.00348	CcSEcCtD
Vancomycin—Hypersensitivity—Cisplatin—esophageal cancer	0.00336	0.00336	CcSEcCtD
Vancomycin—Infection—Capecitabine—esophageal cancer	0.00334	0.00334	CcSEcCtD
Vancomycin—Erythema multiforme—Methotrexate—esophageal cancer	0.00333	0.00333	CcSEcCtD
Vancomycin—Nervous system disorder—Capecitabine—esophageal cancer	0.0033	0.0033	CcSEcCtD
Vancomycin—Thrombocytopenia—Capecitabine—esophageal cancer	0.00329	0.00329	CcSEcCtD
Vancomycin—Tinnitus—Methotrexate—esophageal cancer	0.00328	0.00328	CcSEcCtD
Vancomycin—Tachycardia—Capecitabine—esophageal cancer	0.00328	0.00328	CcSEcCtD
Vancomycin—Asthenia—Cisplatin—esophageal cancer	0.00327	0.00327	CcSEcCtD
Vancomycin—Skin disorder—Capecitabine—esophageal cancer	0.00327	0.00327	CcSEcCtD
Vancomycin—Chills—Methotrexate—esophageal cancer	0.00316	0.00316	CcSEcCtD
Vancomycin—Hypotension—Capecitabine—esophageal cancer	0.00314	0.00314	CcSEcCtD
Vancomycin—Erythema—Methotrexate—esophageal cancer	0.00307	0.00307	CcSEcCtD
Vancomycin—Malnutrition—Methotrexate—esophageal cancer	0.00307	0.00307	CcSEcCtD
Vancomycin—Insomnia—Capecitabine—esophageal cancer	0.00304	0.00304	CcSEcCtD
Vancomycin—Dyspnoea—Capecitabine—esophageal cancer	0.003	0.003	CcSEcCtD
Vancomycin—Back pain—Methotrexate—esophageal cancer	0.00297	0.00297	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.0029	0.0029	CcSEcCtD
Vancomycin—Vomiting—Cisplatin—esophageal cancer	0.0029	0.0029	CcSEcCtD
Vancomycin—Fatigue—Capecitabine—esophageal cancer	0.0029	0.0029	CcSEcCtD
Vancomycin—Rash—Cisplatin—esophageal cancer	0.00288	0.00288	CcSEcCtD
Vancomycin—Pain—Capecitabine—esophageal cancer	0.00288	0.00288	CcSEcCtD
Vancomycin—Constipation—Capecitabine—esophageal cancer	0.00288	0.00288	CcSEcCtD
Vancomycin—Dermatitis—Cisplatin—esophageal cancer	0.00287	0.00287	CcSEcCtD
Vancomycin—Anaemia—Methotrexate—esophageal cancer	0.00283	0.00283	CcSEcCtD
Vancomycin—Vertigo—Methotrexate—esophageal cancer	0.00276	0.00276	CcSEcCtD
Vancomycin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00275	0.00275	CcSEcCtD
Vancomycin—Nausea—Cisplatin—esophageal cancer	0.00271	0.00271	CcSEcCtD
Vancomycin—Urticaria—Capecitabine—esophageal cancer	0.00267	0.00267	CcSEcCtD
Vancomycin—Abdominal pain—Capecitabine—esophageal cancer	0.00266	0.00266	CcSEcCtD
Vancomycin—Body temperature increased—Capecitabine—esophageal cancer	0.00266	0.00266	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00259	0.00259	CcSEcCtD
Vancomycin—Anaphylactic shock—Methotrexate—esophageal cancer	0.0025	0.0025	CcSEcCtD
Vancomycin—Infection—Methotrexate—esophageal cancer	0.00249	0.00249	CcSEcCtD
Vancomycin—Hypersensitivity—Capecitabine—esophageal cancer	0.00248	0.00248	CcSEcCtD
Vancomycin—Nervous system disorder—Methotrexate—esophageal cancer	0.00245	0.00245	CcSEcCtD
Vancomycin—Thrombocytopenia—Methotrexate—esophageal cancer	0.00245	0.00245	CcSEcCtD
Vancomycin—Skin disorder—Methotrexate—esophageal cancer	0.00243	0.00243	CcSEcCtD
Vancomycin—Asthenia—Capecitabine—esophageal cancer	0.00241	0.00241	CcSEcCtD
Vancomycin—Pruritus—Capecitabine—esophageal cancer	0.00238	0.00238	CcSEcCtD
Vancomycin—Hypotension—Methotrexate—esophageal cancer	0.00234	0.00234	CcSEcCtD
Vancomycin—Insomnia—Methotrexate—esophageal cancer	0.00226	0.00226	CcSEcCtD
Vancomycin—Dyspnoea—Methotrexate—esophageal cancer	0.00223	0.00223	CcSEcCtD
Vancomycin—Dizziness—Capecitabine—esophageal cancer	0.00222	0.00222	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00216	0.00216	CcSEcCtD
Vancomycin—Fatigue—Methotrexate—esophageal cancer	0.00216	0.00216	CcSEcCtD
Vancomycin—Pain—Methotrexate—esophageal cancer	0.00214	0.00214	CcSEcCtD
Vancomycin—Vomiting—Capecitabine—esophageal cancer	0.00214	0.00214	CcSEcCtD
Vancomycin—Rash—Capecitabine—esophageal cancer	0.00212	0.00212	CcSEcCtD
Vancomycin—Dermatitis—Capecitabine—esophageal cancer	0.00212	0.00212	CcSEcCtD
Vancomycin—Headache—Capecitabine—esophageal cancer	0.00211	0.00211	CcSEcCtD
Vancomycin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00205	0.00205	CcSEcCtD
Vancomycin—Nausea—Capecitabine—esophageal cancer	0.002	0.002	CcSEcCtD
Vancomycin—Urticaria—Methotrexate—esophageal cancer	0.00199	0.00199	CcSEcCtD
Vancomycin—Abdominal pain—Methotrexate—esophageal cancer	0.00198	0.00198	CcSEcCtD
Vancomycin—Body temperature increased—Methotrexate—esophageal cancer	0.00198	0.00198	CcSEcCtD
Vancomycin—Hypersensitivity—Methotrexate—esophageal cancer	0.00184	0.00184	CcSEcCtD
Vancomycin—Asthenia—Methotrexate—esophageal cancer	0.0018	0.0018	CcSEcCtD
Vancomycin—Pruritus—Methotrexate—esophageal cancer	0.00177	0.00177	CcSEcCtD
Vancomycin—Dizziness—Methotrexate—esophageal cancer	0.00166	0.00166	CcSEcCtD
Vancomycin—Vomiting—Methotrexate—esophageal cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Rash—Methotrexate—esophageal cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Dermatitis—Methotrexate—esophageal cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Headache—Methotrexate—esophageal cancer	0.00157	0.00157	CcSEcCtD
Vancomycin—Nausea—Methotrexate—esophageal cancer	0.00149	0.00149	CcSEcCtD
